Hey, if the premium is good enough, let it come. Would like a bit more time for WP and co to prove themselves, but right now I'd consider any and all good business cases.
Looks like all trials of HSV2 have now been wound down and no more trials without external funding. Unless external funding can be found I still vote to divest. We're still paying the salary of researches, after all.
Hey, if the premium is good enough, let it come. Would like a...
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.31 |
Change
0.000(0.00%) |
Mkt cap ! $351.9M | |||
| Open | High | Low | Value | Volume |
| $18.30 | $19.00 | $18.00 | $363.4K | 19.82K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 500 | $18.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.50 | 1000 | 1 |
View Market Depth
| Last trade - 15.59pm 01/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |